The progression of severe aplastic anemia to hypoplastic leukemia in a long-term observation after the administration of pegylated rHuMGDF

Thrombopoietin (TPO) is a critical regulator of hematopoiesis. We previously reported that a severe aplastic anemia (SAA) who received a short-term administration of pegylated recombinant human megakaryocyte growth and development factor (rHuMGDF). A trilineage hematologic response was induced, howe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hematol Rep
Main Authors: Ishikawa, Maho, Matsuda, Akira, Okamura, Daisuke, Maeda, Tomoya, Kawai, Nobutaka, Asou, Norio, Bessho, Masami
Formato: Artigo
Idioma:Inglês
Publicado: PAGEPress Publications, Pavia, Italy 2018
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151347/
https://ncbi.nlm.nih.gov/pubmed/30283622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2018.7679
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares